Search Results - Manik Chatterjee

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Efficient transient transfection of human multiple myeloma cells by electroporation--an appraisal. by Torsten Steinbrunn, Manik Chatterjee, Ralf C Bargou, Thorsten Stühmer

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  2. 2

    Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab by Vera Dufner, Cyrus M. Sayehli, Manik Chatterjee, Horst D. Hummel, Götz Gelbrich, Ralf C. Bargou, Maria-Elisabeth Goebeler

    Published in Blood Advances (2019-08-01)
    Get full text
    Article


  3. 3

    Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells by Joelle C. Boulos, Mohamed E. M. Saeed, Manik Chatterjee, Yagmur Bülbül, Francesco Crudo, Doris Marko, Markus Munder, Sabine M. Klauck, Thomas Efferth

    Published in Pharmaceuticals (2021-11-01)
    Get full text
    Article


  4. 4

    The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma by Manik Chatterjee, Mindaugas Andrulis, Thorsten Stühmer, Elisabeth Müller, Claudia Hofmann, Torsten Steinbrunn, Tanja Heimberger, Heike Schraud, Stefanie Kressmann, Hermann Einsele, Ralf C. Bargou

    Published in Haematologica (2013-07-01)
    Get full text
    Article


  5. 5

    GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6 by Leo Rasche, Johannes Duell, Inês C. Castro, Valentina Dubljevic, Manik Chatterjee, Stefan Knop, Frank Hensel, Andreas Rosenwald, Hermann Einsele, Max S. Topp, Stephanie Brändlein

    Published in Haematologica (2015-03-01)
    Get full text
    Article


  6. 6

    Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate by Daniela Brünnert, Raina Seupel, Pankaj Goyal, Matthias Bach, Heike Schraud, Stefanie Kirner, Eva Köster, Doris Feineis, Ralf C. Bargou, Andreas Schlosser, Gerhard Bringmann, Manik Chatterjee

    Published in Pharmaceuticals (2023-08-01)
    Get full text
    Article


  7. 7

    Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy by Monica Galli, Manik Chatterjee, Mariella Grasso, Giorgina Specchia, Hila Magen, Hermann Einsele, Ivana Celeghini, Paola Barbieri, David Paoletti, Silvia Pace, Ralph D. Sanderson, Alessandro Rambaldi, Arnon Nagler

    Published in Haematologica (2018-10-01)
    Get full text
    Article


  8. 8

    Rapid response to selpercatinib in RET fusion positive pancreatic neuroendocrine carcinoma confirmed by smartwatch by Barbara Deschler-Baier, Markus Krebs, Matthias Kroiss, Manik Chatterjee, Daniel Gundel, Christian Kestler, Alexander Kerscher, Volker Kunzmann, Silke Appenzeller, Katja Maurus, Andreas Rosenwald, Ralf Bargou, Elena Gerhard-Hartmann, Vivek Venkataramani

    Published in npj Precision Oncology (2024-07-01)
    Get full text
    Article


  9. 9

    RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS by Marcel Seibold, Thorsten Stühmer, Nadine Kremer, Anja Mottok, Claus-Jürgen Scholz, Andreas Schlosser, Ellen Leich, Ulrike Holzgrabe, Daniela Brünnert, Santiago Barrio, K. Martin Kortüm, Antonio G. Solimando, Manik Chatterjee, Hermann Einsele, Andreas Rosenwald, Ralf C. Bargou, Torsten Steinbrunn

    Published in Haematologica (2019-10-01)
    Get full text
    Article


Search Tools: